Peritoneal Cancer - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Peritoneal cancer – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Peritoneal cancer pipeline landscape. It covers
|
12-Oct-2021
|
2500
|
Medulloblastoma - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Medulloblastoma – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Medulloblastoma pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
1500
|
Rosacea - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Rosacea – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Rosacea pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
2000
|
Stomatitis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Stomatitis – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Stomatitis pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
1500
|
Primary Ciliary Dyskinesia - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Primary Ciliary Dyskinesia – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Primary Ciliary Dyskinesia pipeline landscape.
|
12-Oct-2021
|
1500
|
Chondrosarcoma - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Chondrosarcoma – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Chondrosarcoma pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
1500
|
TCR therapy - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “TCR therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 35+ pipeline drugs in TCR therapy pipeline landscape. It covers
|
12-Oct-2021
|
2000
|
TIL therapy - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “TIL therapy – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in TIL therapy pipeline landscape. It covers
|
12-Oct-2021
|
1500
|
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Antisense Oligonucleotide Therapeutics – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Antisense Oligonucleotide Therapeutics pipeline landscape.
|
12-Oct-2021
|
1500
|
Ocular Inflammation and Pain - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Ocular Inflammation and Pain – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Ocular Inflammation and Pain
|
12-Oct-2021
|
1500
|
Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Inflammation and Pain Post Cataract Surgery – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Inflammation and
|
12-Oct-2021
|
1500
|
T-Cell Acute Lymphoblastic Leukemia - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “T-Cell Acute Lymphoblastic Leukemia – Pipeline Insight, 2021,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in T-Cell Acute Lymphoblastic Leukemia
|
12-Oct-2021
|
1500
|
Mucosa-associated Lymphoid Tissue (MALT) Lymphoma - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Mucosa-associated Lymphoid Tissue (MALT) Lymphoma – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Mucosa-associated Lymphoid Tissue
|
12-Oct-2021
|
1500
|
Neurofibromatosis - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Neurofibromatosis - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Neurofibromatosis pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
1500
|
Beta-thalassaemia - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Beta-thalassaemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Beta-thalassaemia pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
2000
|
Bullous pemphigoid - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Bullous pemphigoid - Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Bullous pemphigoid pipeline landscape. It covers
|
12-Oct-2021
|
1500
|
Lyme Disease - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Lyme Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Lyme Disease pipeline landscape. It covers
|
12-Oct-2021
|
1500
|
Fibrodysplasia ossificans progressiva - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Fibrodysplasia ossificans progressiva - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Fibrodysplasia ossificans progressiva pipeline landscape.
|
12-Oct-2021
|
1500
|
Hypertriglyceridemia - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Hypertriglyceridemia - Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in Hypertriglyceridemia pipeline landscape. It covers the pipeline
|
12-Oct-2021
|
2000
|
Chikungunya virus infections - Pipeline Insight, 2021
No. of Pages: 60
Researcher’s, “Chikungunya virus infections - Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Chikungunya virus infections pipeline landscape.
|
12-Oct-2021
|
1500
|
